WallStreetZenWallStreetZen

NASDAQ: XAIR
Beyond Air Inc Stock

$0.56-0.02 (-3.45%)
Updated Jul 17, 2024
XAIR Price
$0.56
Fair Value Price
-$0.24
Market Cap
$25.70M
52 Week Low
$0.53
52 Week High
$4.17
P/E
-0.31x
P/B
1.03x
P/S
49.78x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.16M
Earnings
-$60.24M
Gross Margin
-112.8%
Operating Margin
-4,946.51%
Profit Margin
-5,197.8%
Debt to Equity
1.19
Operating Cash Flow
-$56M
Beta
0.68
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

XAIR Overview

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how XAIR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

XAIR ($0.56) is overvalued by 337.24% relative to our estimate of its Fair Value price of -$0.24 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
XAIR ($0.56) is not significantly undervalued (337.24%) relative to our estimate of its Fair Value price of -$0.24 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
XAIR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more XAIR due diligence checks available for Premium users.

Be the first to know about important XAIR news, forecast changes, insider trades & much more!

XAIR News

Valuation

XAIR fair value

Fair Value of XAIR stock based on Discounted Cash Flow (DCF)
Price
$0.56
Fair Value
-$0.24
Undervalued by
337.24%
XAIR ($0.56) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
XAIR ($0.56) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
XAIR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

XAIR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.31x
Industry
30.16x
Market
30.24x

XAIR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.03x
Industry
3.92x
XAIR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

XAIR's financial health

Profit margin

Revenue
$470.0k
Net Income
-$13.7M
Profit Margin
-2,916.4%
XAIR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
XAIR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$57.0M
Liabilities
$29.8M
Debt to equity
1.19
XAIR's short-term assets ($43.94M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XAIR's short-term assets ($43.94M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XAIR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
XAIR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$10.7M
Investing
-$1.7M
Financing
$15.9M
XAIR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

XAIR vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
XAIR$25.70M-3.28%-0.31x1.03x
AXDX$25.58M+2.65%-0.26x-0.99x
NMTC$24.13M-6.00%-1.51x6.26x
RPID$27.86M-5.80%-0.54x0.26x
VTAK$23.10M-3.17%10.89x1.25x

Beyond Air Stock FAQ

What is Beyond Air's quote symbol?

(NASDAQ: XAIR) Beyond Air trades on the NASDAQ under the ticker symbol XAIR. Beyond Air stock quotes can also be displayed as NASDAQ: XAIR.

If you're new to stock investing, here's how to buy Beyond Air stock.

What is the 52 week high and low for Beyond Air (NASDAQ: XAIR)?

(NASDAQ: XAIR) Beyond Air's 52-week high was $4.17, and its 52-week low was $0.53. It is currently -86.57% from its 52-week high and 6.46% from its 52-week low.

How much is Beyond Air stock worth today?

(NASDAQ: XAIR) Beyond Air currently has 45,900,821 outstanding shares. With Beyond Air stock trading at $0.56 per share, the total value of Beyond Air stock (market capitalization) is $25.70M.

Beyond Air stock was originally listed at a price of $5.88 in May 8, 2019. If you had invested in Beyond Air stock at $5.88, your return over the last 5 years would have been -90.47%, for an annualized return of -37.51% (not including any dividends or dividend reinvestments).

How much is Beyond Air's stock price per share?

(NASDAQ: XAIR) Beyond Air stock price per share is $0.56 today (as of Jul 17, 2024).

What is Beyond Air's Market Cap?

(NASDAQ: XAIR) Beyond Air's market cap is $25.70M, as of Jul 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Beyond Air's market cap is calculated by multiplying XAIR's current stock price of $0.56 by XAIR's total outstanding shares of 45,900,821.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.